These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17071485)

  • 41. Childhood lymphomas in Yemen. Clinicopathological study.
    Al-Samawi AS; Aulaqi SM; Al-Thobhani AK
    Saudi Med J; 2009 Sep; 30(9):1192-6. PubMed ID: 19750266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mortality from Hodgkin's disease and other lymphomas in Europe, 1960-1990.
    Levi F; La Vecchia C; Lucchini F; Te VC; Franceschi S
    Oncology; 1995; 52(2):93-6. PubMed ID: 7854782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of thyroid carcinoma with malignant lymphoma.
    Bakri KM; Shimaoka K; Gajera R; Getaz EP; Friedman M; Walsh D; Tsukada Y
    Jpn J Clin Oncol; 1983 Dec; 13(4):645-55. PubMed ID: 6645082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphoma cases referred to the radiation oncology service of a tertiary referral university hospital in Karachi, Pakistan: a retrospective study.
    Abbasi AN; Zahid S; Karsan F; Ali N; Bhurgri Y
    Asian Pac J Cancer Prev; 2010; 11(1):107-10. PubMed ID: 20593938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Value of ultrasonics in diagnosing the onset of lymphomatous liver lesions].
    Bruneton JN; Balu-Maestro C; Bourry J; Thyss A; Normand F; Santini N; Schneider M
    Nouv Rev Fr Hematol (1978); 1986; 28(6):365-9. PubMed ID: 3550693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma.
    Kewalramani T; Nimer SD; Zelenetz AD; Malhotra S; Qin J; Yahalom J; Moskowitz CH
    Bone Marrow Transplant; 2003 Oct; 32(7):673-9. PubMed ID: 13130314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic markers in malignant lymphoma: an analysis of 1,198 patients treated at a single centre.
    Low SE; Horsman JM; Hancock H; Walters SJ; Hancock BW
    Int J Oncol; 2001 Dec; 19(6):1203-9. PubMed ID: 11713590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant lymphoma in first-degree blood relatives.
    Haim N; Cohen Y; Robinson E
    Cancer; 1982 May; 49(10):2197-200. PubMed ID: 7074535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigrees.
    Wiernik PH; Dutcher JP
    J Investig Med; 2024 Jan; 72(1):26-31. PubMed ID: 37864488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer risks among relatives of children with Hodgkin and non-Hodgkin lymphoma.
    Pang D; Alston RD; Eden TO; Birch JM
    Int J Cancer; 2008 Sep; 123(6):1407-10. PubMed ID: 18561317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease.
    Silver RT; Case DC; Wheeler RH; Miller TP; Stein RS; Stuart JJ; Peterson BA; Rivkin SE; Golomb HM; Costanzi
    J Clin Oncol; 1991 May; 9(5):754-61. PubMed ID: 2016617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database.
    Varterasian ML; Graff JJ; Severson RK; Weiss L; al-Katib AM; Kalemkerian GP
    Cancer Invest; 2000; 18(4):303-8. PubMed ID: 10808365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.
    Yamamoto K; Ikeda S; Hanyu N; Takeda S; Yanagisawa N
    J Med Genet; 1998 Jan; 35(1):23-30. PubMed ID: 9475090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
    Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ascertainment bias causes false signal of anticipation in genetic prion disease.
    Minikel EV; Zerr I; Collins SJ; Ponto C; Boyd A; Klug G; Karch A; Kenny J; Collinge J; Takada LT; Forner S; Fong JC; Mead S; Geschwind MD
    Am J Hum Genet; 2014 Oct; 95(4):371-82. PubMed ID: 25279981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancers in relatives of children with non-Hodgkin's lymphoma.
    Le Bihan C; Moutou C; Chompret A; Abel A; Poisson N; Brugières L; Lemerle J; Bonaïti-Pelliè C
    Leuk Res; 1996 Feb; 20(2):181-6. PubMed ID: 8628018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of non-Hodgkin's lymphoma in patients treated for Hodgkin's disease.
    Prósper F; Robledo C; Cuesta B; Rifón J; Borbolla JR; Pardo J; Rocha E
    Leuk Lymphoma; 1994 Feb; 12(5-6):457-62. PubMed ID: 8180608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric Hodgkin's and non-Hodgkin's lymphomas: a retrospective analysis at the Children's Hospital of New Orleans.
    Somjee SS; Mani S; Bufkin R; Hebert L; Velez MC; Yu LC
    J La State Med Soc; 2005; 157(6):325-8. PubMed ID: 16579345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
    Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
    Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preliminary evidence of genetic anticipation in Graves' disease.
    Brix TH; Petersen HC; Iachine I; Hegedüs L
    Thyroid; 2003 May; 13(5):447-51. PubMed ID: 12855011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.